About CHIMagents
CHIMagents was established in 2019 and is based in Guildford, United Kingdom. Operations are centered in the pharmaceutical sector, with a focus on manufacturing potential antiviral drugs and vaccines for testing. The company is led by co-founders Martin Schutten and Adrian Wildfire, the latter serving as CEO. Activities support antiviral research through production of these specialized products in a controlled environment.
- Headquarter Guildford, United Kingdom
- Founders Martin Schutten, Adrian Wildfire
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Hvivo Services Limited
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Open Orphan
(Jul 15, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of CHIMagents
Detailed funding history for CHIMagents
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in CHIMagents
CHIMagents has secured backing from 1 investor. Prominent investors backing the company include Open Orphan.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provider of testing vaccines & antivirals and CRO pharmaceutical services
|
Locked | Locked | Locked |
Investor details for CHIMagents
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CHIMagents
Investment portfolio details for CHIMagents
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - CHIMagents
Detailed financials for CHIMagents
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Chimagents Comparisons
Peer comparison for CHIMagents
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CHIMagents
Detailed competitors of CHIMagents
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Chimagents
Complete news archive for CHIMagents
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CHIMagents
CHIMagents was founded in 2019.
CHIMagents is headquartered in Guildford, United Kingdom.
Adrian Wildfire is the current CEO of CHIMagents. They have also founded this company.
CHIMagents was established in 2019 and is based in Guildford, United Kingdom. Operations are centered in the pharmaceutical sector, with a focus on manufacturing potential antiviral drugs and vaccines for testing. The company is led by co-founders Martin Schutten and Adrian Wildfire, the latter serving as CEO. Activities support antiviral research through production of these specialized products in a controlled environment.
CHIMagents has 1 investor. Key investors include Open Orphan.